Fig. 8From: A novel NET-related gene signature for predicting DLBCL prognosisRelationships between risk score and therapeutic sensitivity and molecular docking simulation. A Treatment response of axitinib. B Treatment response of OSI_027. C Left: HIF1A- AXITINIB. Right: Chemical formula of AXITINIB. D Left: HIF1A-SORAFENIB. Right: Chemical formula for SORAFENIBBack to article page